Feng-Ming Kong, MD, PhD, FASTRO, FACR

University of Hong Kong
Hong Kong, Hong Kong, United States

Disclosures:

• Employment: The University of Hong Kong, Hong Kong, China:Professor:Employee
• Compensation: Varian: Research Grants, Research Funding, Research Salary Support, Compensation Payment-End Date: 12/2020
• Ownership: none
• Leadership: none

Presentation(s):

• 284 - A Phase II Randomized Trial of Radical Resection vs. Stereotactic Body Radiation Therapy (SBRT) in Patients with Operable Stage I Non-Small Cell Lung Cancer (NSCLC): Final Report Of RTOG-F3502

  Tuesday, October 1, 2024
  12:55 PM – 1:05 PM ET